[LS-37] Luncheon Seminar 37　Should we start MAOB inhibitor therapy with monotherapy or in combination with levodopa ?

[LS-37-1] MAO-B inhibitors as adjunctive therapy to L-dopa in early Parkinson’s disease

Tetsuya Maeda (Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Japan)